The core scientific challenge in cryopreservation isn't achieving low temperatures, but avoiding the formation of ice. When water freezes, it expands and shatters cells. The goal is vitrification: cooling tissue so rapidly that it turns into a stable, glass-like state without forming destructive ice crystals.

Instead of forcing a microbe to create a foreign product through extensive engineering, first identify what it is predisposed to make. Then, apply minimal genetic "nudges" to optimize existing pathways. This "downhill" approach creates a much more efficient and viable R&D process.

The problem is unique because engineering improvements, like faster temperature modulation, can lessen biological hurdles. For instance, more rapid cooling reduces the time spent in the 'danger zone' for ice crystal formation, thereby lowering the required concentration of potentially toxic cryoprotectant agents. This creates powerful leverage not common in biology.

The initial, highly valuable application for reversible organ cryopreservation is not futuristic hibernation but solving the urgent logistical crisis in organ transplantation. Extending an organ's viability from a few hours to days transforms an emergency process involving private jets into a schedulable, cost-effective operation.

Despite known toxicity and FDA concerns, DMSO remains the standard cryopreservative because of its extensive clinical history and the high cost required to validate alternatives. Established protocols, regulatory history, and economic advantages create a significant barrier to innovation, trapping the industry in a legacy solution.

Reversible cryopreservation is already a reality for human embryos, which have remained viable after 30 years in storage. The central challenge for companies like Until is not a fundamental scientific breakthrough, but rather solving the complex engineering problems of applying this proven concept to larger biological systems like organs.

Instead of screening billions of nature's existing proteins (a search problem), AI-powered de novo design creates entirely new proteins for specific functions from scratch. This moves the paradigm from hoping to find a match to intentionally engineering the desired molecule.

The principle of hormesis shows that stressors like fasting and cold exposure trigger a self-preservation state in cells. This "hunker down" mode activates repair mechanisms like sirtuin proteins, which clean up cellular damage, making these seemingly negative activities profoundly healthy.

Intermittent challenges such as temperature extremes, fasting, and certain plant compounds trigger the same underlying genetic stress-response pathways. This concept, called hormesis, builds systemic resilience against the general stressors of aging and normal metabolism, providing cross-cutting benefits from varied inputs.